Clinical Trials on Liver Cirrhosis in Hong Kong
Total 465 results
-
The University of Hong KongActive, not recruiting
-
SuperSonic ImagineJohann Wolfgang Goethe University HospitalCompletedLiver FibrosisDenmark, France, Germany, Belgium, China, Greece, Hong Kong, Italy, Romania
-
Virion TherapeuticsRecruitingChronic Hepatitis BHong Kong, New Zealand
-
GlaxoSmithKlineCompletedCarcinoma, HepatocellularTaiwan, United States, Hong Kong
-
GlaxoSmithKlineCompletedCarcinoma, HepatocellularTaiwan, Thailand, Hong Kong
-
SCG Cell Therapy Pte. Ltd.RecruitingHepatocellular Carcinoma Recurrent | Hepatitis B Virus Related Hepatocellular CarcinomaUnited States, Singapore, Hong Kong
-
Matrix PharmaceuticalUnknown
-
Bukwang PharmaceuticalCompleted
-
AstraZenecaCompletedCancer | Advanced Hepatocellular CarcinomaKorea, Republic of, Hong Kong
-
Light Sciences OncologyCompletedCarcinoma, Hepatocellular | Liver NeoplasmsTaiwan, Hong Kong, Singapore
-
Novartis PharmaceuticalsTerminatedHepatocellular CarcinomaHong Kong, Taiwan, Thailand
-
NovartisNovartis PharmaceuticalsCompletedHepatitis BHong Kong, Singapore, New Zealand
-
LG Life SciencesUnknownChronic Hepatitis BChina, Korea, Republic of
-
GlaxoSmithKlineCompletedFibrosis | Chronic Hepatitis B | Hepatitis B, Chronic | CirrhosisTaiwan, Korea, Republic of, Singapore, Hong Kong, Vietnam
-
Galvanize Therapeutics, Inc.TerminatedCancer of Lung, Kidney or LiverHong Kong, Spain, Netherlands
-
Hoffmann-La RocheTerminatedHepatitis B, ChronicHong Kong, Taiwan, New Zealand
-
Hoffmann-La RocheCompletedHepatitis B, ChronicHong Kong, China
-
LG Life SciencesCompletedChronic Hepatitis BChina, Korea, Republic of
-
Humanity and Health Research CentreBeijing 302 Hospital; Nanfang Hospital of Southern Medical University; Yamanashi...Recruiting
-
Hoffmann-La RocheCompleted
-
Andreas Benesic, MDMetaHeps GmbHUnknownAdverse Reaction to Drug | Drug-induced Disorder of LiverHong Kong, Australia, Germany, Japan, Korea, Republic of
-
HK inno.N CorporationCompletedLiver Cirrhosis | Liver FibrosisKorea, Republic of
-
PharmaNest, IncIcahn School of Medicine at Mount Sinai; Chinese University of Hong Kong; Imperial... and other collaboratorsNot yet recruitingMetabolic Dysfunction-associated Steatotic Liver DiseaseUnited States, Hong Kong, United Kingdom, Spain
-
Enanta Pharmaceuticals, IncPharmaceutical Research AssociatesCompletedChronic HBV InfectionHong Kong, Taiwan
-
Enyo PharmaCompletedHepatitis B, ChronicHong Kong, Korea, Republic of, Taiwan
-
Gilead SciencesF-star Therapeutics, Inc.TerminatedChronic Hepatitis BKorea, Republic of, Hong Kong
-
GlaxoSmithKlineIonis Pharmaceuticals, Inc.CompletedHepatitis B | Chronic Hepatitis B AtypicalKorea, Republic of, Hong Kong
-
PfizerTerminatedHepatitis C, ChronicTaiwan, Singapore, India, Korea, Republic of, Hong Kong
-
Novartis PharmaceuticalsTerminatedAdvanced Hepatocellular Carcinoma With c-MET DysregulationChina, Hong Kong, Thailand, Singapore
-
NGM Biopharmaceuticals, IncCompletedNonalcoholic Steatohepatitis | Compensated CirrhosisUnited States, Australia, Belgium, France, Germany, Hong Kong, Poland, Puerto Rico, United Kingdom
-
National Medical Research Council (NMRC), SingaporeCompletedLiver CancerNew Zealand, Hong Kong, Indonesia, Malaysia, Pakistan, Singapore
-
NovartisNovartis PharmaceuticalsCompletedHepatitis BCanada, France, United States, China
-
Arrowhead PharmaceuticalsTerminatedHepatitis BKorea, Republic of, Germany, China
-
Progen PharmaceuticalsTerminatedCancer | Hepatocellular Carcinoma | Primary Liver Cancer | Liver Cancer | HepatomaHong Kong, Singapore, United States, Australia, Canada, Italy, Malaysia, Spain, Taiwan, Thailand
-
Ligand PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, Hong Kong, Taiwan
-
AstraZenecaIonis Pharmaceuticals, Inc.CompletedAdvanced Adult Hepatocellular Carcinoma | Hepatocellular Carcinoma MetastaticKorea, Republic of, Taiwan, Hong Kong, Japan
-
Hoffmann-La RocheCompletedCarcinoma, HepatocellularUnited States, Hong Kong, Taiwan, Singapore
-
PharmaKingCompletedNon-alcholic Fatty Liver DiseaseKorea, Republic of
-
Novartis PharmaceuticalsWithdrawnAdvanced Hepatocellular CarcinomaGermany, Australia, Hong Kong, Switzerland, Spain, France, United States
-
PowderMedCompletedChronic Hepatitis BThailand, Hong Kong, Singapore, Taiwan
-
National Institute of Diabetes and Digestive and...National Cancer Institute (NCI); National Institute of Allergy and Infectious... and other collaboratorsCompletedFibrosis, Liver | Cirrhosis, Liver | Hepatic Cirrhosis | Chronic Hepatitis cUnited States
-
Hoffmann-La RocheCompletedCarcinoma, Hepatocellular | Liver Metastases | Biliary Tract Cancer | Secondary Liver CancerKorea, Republic of, Denmark, Spain, Taiwan, United States, Hong Kong
-
Boston Scientific CorporationRecruitingPancreatic Diseases | Bile Duct Diseases | Hepatic DiseaseUnited States, India, China, Hong Kong
-
Triangle PharmaceuticalsUnknownHepatitis BUnited States, Canada, China, France, Singapore
-
BayerCompletedCarcinoma, HepatocellularHong Kong, Taiwan, Korea, Republic of, Singapore
-
LG Life SciencesCompletedChronic Hepatitis BKorea, Republic of, China
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationTerminatedCancer | Hepatocellular Carcinoma | Liver CancerKorea, Republic of, Taiwan, Hong Kong, China
-
Novartis PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, Hong Kong, Taiwan, Korea, Republic of
-
Arrowhead PharmaceuticalsCompletedHepatitis BAustralia, Hong Kong, New Zealand
-
Novo Nordisk A/SCompletedCirrhosis | Acquired Bleeding DisorderGermany, United Kingdom, Spain, Taiwan, France, Italy, Austria, Czech Republic, Poland, Denmark, Finland, Hong Kong